Ge Shen

No.199 You Anmen Outer Street
Fengtai, 100069, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Case Report: Dynamic TKI combination strategies for EGFR-mutant NSCLC with acquired ROS1 fusion and brain metastases.

Case Report: Dynamic TKI combination strategies for EGFR-mutant NSCLC with acquired ROS1 fusion and brain metastases.

Journal: Frontiers in oncology
Published: March 08, 2026

Brigatinib in ALK-fused, Low-grade Pediatric Angiocentric Glioma with Multiple Extracranial Metastases: A Case Report.

Brigatinib in ALK-fused, Low-grade Pediatric Angiocentric Glioma with Multiple Extracranial Metastases: A Case Report.

Journal: CNS & neurological disorders drug targets
Published: November 13, 2025

First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFR-mutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial.

First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFR-mutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial.

Journal: Signal transduction and targeted therapy
Published: June 06, 2025

Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastases.

Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastases.

Journal: Frontiers in oncology
Published: May 20, 2022

Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports.

Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports.

Journal: The Journal of international medical research
Published: April 26, 2022

Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report.

Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report.

Journal: Medicine
Published: September 15, 2020

Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case Report.

Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case Report.

Journal: The oncologist
Published: August 09, 2019

Immunomodulatory features of radiotherapy in lung carcinoma.

Immunomodulatory features of radiotherapy in lung carcinoma.

Journal: Translational cancer research
Published: July 08, 2019

Retrospective comparison of stereotactic body radiotherapy versus intensity-modulated radiotherapy for stage III ultra-central squamous non-small-cell lung cancer.

Retrospective comparison of stereotactic body radiotherapy versus intensity-modulated radiotherapy for stage III ultra-central squamous non-small-cell lung cancer.

Journal: Future oncology (London, England)
Published: April 06, 2019

Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra-central non-small cell lung cancer.

Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra-central non-small cell lung cancer.

Journal: Thoracic cancer
Published: February 20, 2019

Spatio-temporal evolution of traditional soybean planting structure in Songnen Plain, China in 1996-2016.

Spatio-temporal evolution of traditional soybean planting structure in Songnen Plain, China in 1996-2016.

Journal: Ying yong sheng tai xue bao = The journal of applied ecology
Published: October 17, 2018

Efficacy and safety of bevacizumab treatment for refractory brain edema: Case report.

Efficacy and safety of bevacizumab treatment for refractory brain edema: Case report.

Journal: Medicine
Published: November 03, 2017
Showing 1-12 of 23

Last Updated: 09/26/2026